alpha-Benzoyltriethylamine en es it fr

alpha-Benzoyltriethylamine Brand names, alpha-Benzoyltriethylamine Analogs

alpha-Benzoyltriethylamine Brand Names Mixture

  • No information avaliable

alpha-Benzoyltriethylamine Chemical_Formula

C13H19NO

alpha-Benzoyltriethylamine RX_link

http://www.rxlist.com/cgi/generic3/diethprop.htm

alpha-Benzoyltriethylamine fda sheet

alpha-Benzoyltriethylamine FDA

alpha-Benzoyltriethylamine msds (material safety sheet)

alpha-Benzoyltriethylamine MSDS

alpha-Benzoyltriethylamine Synthesis Reference

No information avaliable

alpha-Benzoyltriethylamine Molecular Weight

205.296 g/mol

alpha-Benzoyltriethylamine Melting Point

No information avaliable

alpha-Benzoyltriethylamine H2O Solubility

No information avaliable

alpha-Benzoyltriethylamine State

No information avaliable

alpha-Benzoyltriethylamine LogP

2.951

alpha-Benzoyltriethylamine Dosage Forms

25 mg tablets and 75 mg controlled-release tablets.

alpha-Benzoyltriethylamine Indication

Used in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction.

alpha-Benzoyltriethylamine Pharmacology

Diethylpropion is a sympathomimetic stimulant drug marketed as an appetite suppressant. Chemically, it is the N,N-diethyl analog of cathinone. Its mechanism of action is similar to other appetite suppressants such as sibutramine, phentermine and dextroamphetamine.

alpha-Benzoyltriethylamine Absorption

Diethylpropion is rapidly absorbed from the GI tract after oral administration.

alpha-Benzoyltriethylamine side effects and Toxicity

The reported oral LD50 for mice is 600 mg/kg, for rats is 250 mg/kg and for dogs is 225 mg/kg. Manifestation of acute overdosage include restlessness, tremor, hyperreflexia, rapid respiration, confusion, assaultiveness, hallucinations, and panic states.

alpha-Benzoyltriethylamine Patient Information

No information avaliable

alpha-Benzoyltriethylamine Organisms Affected

Humans and other mammals